Biblio

Author Title [ Type

] Year

Filters: Author is Yao, Chi-Yuan [Clear All Filters]

Journal Article

Wang Y-H, Lin C-C, Yao C-Y, Hsu C-L, Hou H-A, Tsai C-H, Chou W-C, Tien H-F. A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients. Blood Adv. 2020;4(4):644-654.

Wang Y-H, Hou H-A, Lin C-C, Kuo Y-Y, Yao C-Y, Hsu C-L, Tseng M-H, Tsai C-H, Peng Y-L, Kao C-J, et al. A CIBERSORTx-based immune-cell scoring system could independently predict prognosis of myelodysplastic syndrome patients. Blood Adv. 2021.

Hung S-Y, Lin C-C, Hsu C-L, Yao C-Y, Wang Y-H, Tsai C-H, Hou H-A, Chou W-C, Tien H-F. The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes. Br J Haematol. 2020.

Simon L, Spinella J-F, Yao C-Y, Lavallée V-P, Boivin I, Boucher G, Audemard E, Bordeleau M-E, Lemieux S, Hébert J, et al. High frequency of germline RUNX1 mutations in RUNX1 mutated AML patients. Blood. 2020.

Yao C-Y, Lin C-C, Wang Y-H, Kao C-J, Tsai XCheng-Hong, Hou H-A, Tien H-F, Hsu C-L, Chou W-C. Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood Adv. 2024.

Wang Y-H, Yao C-Y, Lin C-C, Gurashi K, Amaral FMR, Bossenbroek H, Jerez A, Somervaille TCP, Binder M, Patnaik MM, et al. A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia. Br J Haematol. 2023.

Lin C-M, Chang L-C, Shau W-Y, Chen C-L, Yao C-Y, Tien F-M. Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):446.